Actionnariat et activité des initiés pour Inogen, Inc. (INGN): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $5.13 |
| Capitalisation | $139M |
| Bourse | NASDAQ |
| Pays | US |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $92.9M | $143.0M | $196.6M | $198.0M | $212.0M | $235.5M | $187.0M | $125.5M | $113.8M | $103.7M |
| Placements à Court Terme | $21.0M | $31.0M | $43.7M | $11.1M | $19.3M | $10.0M | 0 | $3.0M | 0 | $15.8M |
| Créances | $30.8M | $32.8M | $39.7M | $37.3M | $31.8M | $25.8M | $64.4M | $42.9M | $30.1M | $38.9M |
| Stocks | $14.3M | $18.8M | $27.1M | $35.7M | $24.8M | $31.9M | $34.1M | $21.8M | $24.8M | $26.0M |
| Actifs Courants | $161.5M | $228.5M | $314.6M | $292.2M | $305.7M | $329.2M | $304.6M | $207.1M | $185.5M | $198.3M |
| Immobilisations Corporelles | $25.2M | $20.1M | $22.3M | $25.3M | $37.1M | $63.8M | $64.9M | $70.7M | $62.7M | $52.9M |
| Goodwill | 0 | $2.4M | $2.3M | $33.0M | $33.2M | $33.0M | $32.9M | $10.1M | $9.5M | $10.7M |
| Actifs Incorporels | $241000 | $4.7M | $3.8M | $77.5M | $68.8M | $60.1M | $177000 | $34.6M | $30.5M | $30.8M |
| Actifs Totaux | $214.0M | $275.1M | $375.9M | $447.3M | $461.9M | $489.5M | $405.0M | $326.2M | $296.2M | $298.6M |
| Dettes Fournisseurs | $5.7M | $9.5M | $13.7M | $16.4M | $12.5M | $10.3M | $18.2M | $13.5M | $16.6M | $20.3M |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $22.8M | $33.9M | $46.6M | $50.2M | $56.7M | $61.5M | $65.3M | $72.5M | $76.7M | $63.5M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $32.0M | $48.0M | $65.5M | $102.7M | $112.2M | $119.3M | $107.6M | $121.4M | $122.3M | $106.4M |
| Réserves | -$12.4M | $8.6M | $60.5M | $81.4M | $75.6M | $69.3M | -$14.5M | -$116.9M | -$152.8M | -$175.6M |
| Capitaux Propres | $182.1M | $227.0M | $310.4M | $344.6M | $349.6M | $370.2M | $297.4M | $204.8M | $173.9M | $192.2M |
| Dette Totale | 0 | 0 | 0 | $6.7M | $10.0M | $26.7M | $23.3M | $21.9M | $19.4M | $17.5M |
| Dette Nette | -$113.9M | -$173.9M | -$240.3M | -$202.4M | -$221.2M | -$218.8M | -$163.7M | -$106.5M | -$94.4M | -$102.1M |
| Fonds de Roulement | $138.7M | $194.6M | $268.0M | $242.0M | $249.0M | $267.7M | $239.3M | $134.6M | $108.8M | $134.8M |
Santé financière
| Dette / Capitaux propres | 0.09 |
| Ratio de liquidité | 2.74 |
| Piotroski F-Score | 5 |
| Altman Z-Score | 1.58 |
Rentabilité
| Rentabilité des capitaux propres | -13.17% |
| Rentabilité du capital investi | -13.35% |
| Rentabilité des actifs | -8.61% |
| Marge brute | 48.89% |
| Marge opérationnelle | -8.45% |
| Marge nette | -6.94% |
Entreprises liées: CATX · EPRX · HCAT · HSDT · NNOX · OM · QTRX
Explorer le secteur: Healthcare · Medical - Devices
Plus de sections de INGN: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions